HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Clinical trials for HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New device aims to boost heart function in heart failure patients
Disease control Not yet recruitingThis study looks at how a device called Barostim affects heart function and symptoms in adults with heart failure and reduced pumping ability. About 58 people will get the device implanted and adjusted. The goal is to see if it improves blood flow and exercise capacity.
Matched conditions: HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated May 17, 2026 05:46 UTC
-
New infusion aims to keep severe heart failure patients out of hospital
Disease control Not yet recruitingThis study tests a continuous 6-month infusion of alprostadil (ALP-1) in 600 adults with advanced heart failure and reduced pumping ability. The goal is to see if it delays death, need for a heart transplant, or worsening heart failure compared to a placebo. Participants must hav…
Matched conditions: HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE3 • Sponsor: Biopeutics Co., Ltd • Aim: Disease control
Last updated May 17, 2026 05:45 UTC
-
Smartwatches may help heart failure patients get better care at home
Disease control Not yet recruitingThis study looks at whether using wearable devices like the Apple Watch can help doctors remotely adjust medications for people with both heart failure and atrial fibrillation. About 400 participants will be split into two groups: one gets standard care, the other uses a smartwat…
Matched conditions: HFREF - HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated May 14, 2026 12:05 UTC